IUC26658-92

Abstract Code: IUC26658-92   Efficacy Patterns of First-Line Immune Checkpoint Inhibitor Combinations in Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis Evaluating Ethnic Variations D. Khanna 1, T. Dey 2, E. Blanchard-Cavagis 3,...

IUC26657-91

Abstract Code: IUC26657-91   Sex-based Disparities in Metastatic Renal Cell Carcinoma: Real-World Data from Meet-URO33 Study. M. Zinelli Ronzoni 1, M. Maffezzoli 1, E. Lai 2, E. Verzoni 3, C. Lolli 4, M. Di Napoli 5, A. Signori 6, S. Buti 1, S.E. Rebuzzi 7, D....

IUC26628-89

Abstract Code: IUC26628-89   Real-World Outcomes of Adjuvant Pembrolizumab in Renal Cell Carcinoma: A Single-Centre Experience    O. Okuma 1, C. Nwankwo 1, M. Cortez 1, M. Chipuriro 1, K. Kumar 1 (1) James Cook University Hospital, Middlesbrough – United...

IUC26562-86

Abstract Code: IUC26562-86   Integrating Transcriptomic Profiles and Clinical Outcomes Across MEET-URO Risk Groups in Metastatic Renal Cell Carcinoma: A Comparative Analysis with the IMDC Framework G. Neola 1, N. Salgia 2, A. Moradi 2, S.E. Rebuzzi 3, P. Rescigno...

IUC26559-92

Abstract Code: IUC26559-92   Reduced-Dose Pazopanib as First-Line Therapy in Metastatic Renal Cell Carcinoma: Real-World Evidence from an Immunotherapy-Inaccessible Cohort A. Krishnan M P 1, P. Shenoy 1, N. Devi R 1, A. Menon 1, S. Nawaz 1 (1) Divison of Medical...

IUC25693-90

Abstract Code: IUC25693-90   Real-world effectiveness of pembrolizumab plus axitinib in metastatic renal cell carcinoma in Panama J. Pinto 1, A. Cardenas 2 (1) Head of oncology Unit, Hospital Anita Moreno. Los Santos, Panama – Panama, (2) MD, Oncology Unit,...
error: Content is protected !!